Xcopri 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJA8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,712
Award facts
- Contract value 100% obligated
- $1,712.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $1,712.07. The order was competitively awarded without set-aside designation and has an ultimate completion date of November 25, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency and military healthcare systems. The company's portfolio under the DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for XCOPRI, an antiepileptic medication, reflects the company's role in supplying specialized pharmaceuticals essential to military medical readiness and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJA8Q?
SPE2DR26FJA8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FJA8Q worth?
The government has obligated $1,712 on SPE2DR26FJA8Q.
Is contract SPE2DR26FJA8Q an order under another contract?
Yes. SPE2DR26FJA8Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJA8Q competed?
The extent of competition for SPE2DR26FJA8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award